Search Results - "Schulman, C. C"

Testosterone and COVID-19: A key hormone’s link with the increased mortality in men by Schulman, C.

Get full text

DNA methylation disruption reshapes the hematopoietic differentiation landscape by Izzo, Franco, Lee, Stanley C., Poran, Asaf, Chaligne, Ronan, Gaiti, Federico, Gross, Baptiste, Murali, Rekha R., Deochand, Sunil D., Ang, Chelston, Jones, Philippa Wyndham, Nam, Anna S., Kim, Kyu-Tae, Kothen-Hill, Steven, Schulman, Rafael C., Ki, Michelle, Lhoumaud, Priscillia, Skok, Jane A., Viny, Aaron D., Levine, Ross L., Kenigsberg, Ephraim, Abdel-Wahab, Omar, Landau, Dan A.

“…Mutations in genes involved in DNA methylation (DNAme; for example, TET2 and DNMT3A ) are frequently observed in hematological malignancies 1 – 3 and clonal…”
Get full text

Corrupted coordination of epigenetic modifications leads to diverging chromatin states and transcriptional heterogeneity in CLL by Pastore, Alessandro, Gaiti, Federico, Lu, Sydney X., Brand, Ryan M., Kulm, Scott, Chaligne, Ronan, Gu, Hongcang, Huang, Kevin Y., Stamenova, Elena K., Béguelin, Wendy, Jiang, Yanwen, Schulman, Rafael C., Kim, Kyu-Tae, Alonso, Alicia, Allan, John N., Furman, Richard R., Gnirke, Andreas, Wu, Catherine J., Melnick, Ari M., Meissner, Alexander, Bernstein, Bradley E., Abdel-Wahab, Omar, Landau, Dan A.

“…Cancer evolution is fueled by epigenetic as well as genetic diversity. In chronic lymphocytic leukemia (CLL), intra-tumoral DNA methylation (DNAme)…”
Get full text

Is Erectile Dysfunction the “Tip of the Iceberg” of a Systemic Vascular Disorder? by Montorsi, Piero, Montorsi, Francesco, Schulman, Claude C.

Get full text

Fundamental Concepts Regarding Testosterone Deficiency and Treatment: International Expert Consensus Resolutions by Morgentaler, Abraham, Zitzmann, Michael, Traish, Abdulmaged M, Fox, Anthony W, Jones, T Hugh, Maggi, Mario, Arver, Stefan, Aversa, Antonio, Chan, Juliana C N, Dobs, Adrian S, Hackett, Geoffrey I, Hellstrom, Wayne J, Lim, Peter, Lunenfeld, Bruno, Mskhalaya, George, Schulman, Claude C, Torres, Luiz O

“…To address widespread concerns regarding the medical condition of testosterone (T) deficiency (TD) (male hypogonadism) and its treatment with T therapy, an…”
Get full text

Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations by Wang, C, Nieschlag, E, Swerdloff, R, Behre, H M, Hellstrom, W J, Gooren, L J, Kaufman, J M, Legros, J-J, Lunenfeld, B, Morales, A, Morley, J E, Schulman, C, Thompson, I M, Weidner, W, Wu, F C W

Get full text

Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring by Zviran, Asaf, Schulman, Rafael C., Shah, Minita, Hill, Steven T. K., Deochand, Sunil, Khamnei, Cole C., Maloney, Dillon, Patel, Kristofer, Liao, Will, Widman, Adam J., Wong, Phillip, Callahan, Margaret K., Ha, Gavin, Reed, Sarah, Rotem, Denisse, Frederick, Dennie, Sharova, Tatyana, Miao, Benchun, Kim, Tommy, Gydush, Greg, Rhoades, Justin, Huang, Kevin Y., Omans, Nathaniel D., Bolan, Patrick O., Lipsky, Andrew H., Ang, Chelston, Malbari, Murtaza, Spinelli, Catherine F., Kazancioglu, Selena, Runnels, Alexi M., Fennessey, Samantha, Stolte, Christian, Gaiti, Federico, Inghirami, Giorgio G., Adalsteinsson, Viktor, Houck-Loomis, Brian, Ishii, Jennifer, Wolchok, Jedd D., Boland, Genevieve, Robine, Nicolas, Altorki, Nasser K., Landau, Dan A.

“…In many areas of oncology, we lack sensitive tools to track low-burden disease. Although cell-free DNA (cfDNA) shows promise in detecting cancer mutations, we…”
Get full text

Effect of Endothelin-A Receptor Blockade With Atrasentan on Tumor Progression in Men With Hormone-Refractory Prostate Cancer: A Randomized, Phase II, Placebo-Controlled Trial by CARDUCCI, Michael A, PADLEY, Robert J, SCHMITT, Jennifer L, NELSON, Joel B, BREUL, Jurgen, VOGELZANG, Nicholas J, ZONNENBERG, Bernard A, DALIANI, Danai D, SCHULMON, Claude C, NABULSI, Azmi A, HUMERICKHOUSE, Rod A, WEINBERG, Mark A

“…To evaluate the efficacy and safety of atrasentan (ABT-627), an endothelin-A receptor antagonist, in the treatment of asymptomatic, hormone-refractory…”
Get full text

Improving the management of patients with prostate cancer receiving long‐term androgen deprivation therapy by Schulman, C., Irani, J., Aapro, M.

“…In many patients with prostate cancer, androgen deprivation therapy (ADT) is administered over prolonged periods of time. The benefits of long‐term ADT in…”
Get full text

Erectile Dysfunction Is Associated with a High Prevalence of Hyperlipidemia and Coronary Heart Disease Risk by Roumeguère, Th, Wespes, E, Carpentier, Y, Hoffmann, P, Schulman, C.C

“…Objectives: Erectile dysfunction (ED) is frequently of vascular origin. An association between ED and ischemic heart disease has been suggested as a…”
Get full text

Investigation, treatment and monitoring of late-onset hypogonadism in males by Wang, C, Nieschlag, E, Swerdloff, R, Behre, H M, Hellstrom, W J, Gooren, L J, Kaufman, J M, Legros, J-J, Lunenfeld, B, Morales, A, Morley, J E, Schulman, C, Thompson, I M, Weidner, W, Wu, F C W

Get full text

Role of Bisphosphonates in Prostate Cancer by Saad, Fred, Schulman, Claude C.

“…Objective(s): To investigate the role of bisphosphonates in the long-term supportive care of patients with prostate cancer, an emerging medical challenge…”
Get full text

Investigation, Treatment, and Monitoring of Late‐Onset Hypogonadism in Males: ISA, ISSAM, EAU, EAA, and ASA Recommendations by Wang, C., Nieschlag, E., Swerdloff, R., Behre, H. M., Hellstrom, W. J., Gooren, L. J., Kaufman, J. M., Legros, J.‐J., Lunenfeld, B., Morales, A., Morley, J. E., Schulman, C., Thompson, I. M., Weidner, W., Wu, F. C. W.

Get full text

Investigation, treatment and monitoring of late-onset hypogonadism in males ISA, ISSAM, and EAU recommendations by NIESCHLAG, E, SWERDLOFF, R, WEIDNER, W, WU, F. C. W, BEHRE, H. M, GOOREN, L. J, KAUFMAN, J. M, LEGROS, J.-J, LUNENFELD, B, MORLEY, J. E, SCHULMAN, C, WANG, C

Get full text

Extraperitoneal laparoscopic radical prostatectomy. Results after 50 cases by Bollens, R, Vanden Bossche, M, Roumeguere, T, Damoun, A, Ekane, S, Hoffmann, P, Zlotta, A R, Schulman, C C

“…After an initial experience using transperitoneal laparoscopic radical prostatectomy as described by Vallancien and Guillonneau, we developed a pure…”
Get more information

Skeletal Morbidity in Men with Prostate Cancer: Quality-of-Life Considerations throughout the Continuum of Care by Saad, Fred, Olsson, Carl, Schulman, Claude C.

“…With current treatments, men usually survive many years after being diagnosed with prostate cancer. However, without supportive care, the systemic effects of…”
Get full text

Trans-Obturator Vaginal Tape (TOT ®) for Female Stress Incontinence: One Year Follow-Up in 120 Patients by Roumeguère, Thierry, Quackels, Th, Bollens, R., de Groote, A., Zlotta, A., Bossche, M. Vanden, Schulman, C.

“…The aim of this study was to evaluate the effectiveness of a new minimally invasive surgical procedure, the Trans-obturator Vaginal Tape (TOT ®) in the…”
Get full text

Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men by Djavan, B, Zlotta, A, Remzi, M, Ghawidel, K, Basharkhah, A, Schulman, C C, Marberger, M

“…We compare the ability of total prostate specific antigen (PSA), percent free PSA, PSA density and transition zone PSA density to predict the outcome of repeat…”
Get more information

A Long-Term, Multicenter, Double-Blind Study of an Escherichia Coli Extract (OM-89) in Female Patients with Recurrent Urinary Tract Infections by Bauer, Hartwig W., Alloussi, Schanaz, Egger, Günther, Blümlein, Hans-Martin, Cozma, Gabriel, Schulman, Claude C.

“…To investigate the long-term preventive effect of the immunotherapeutic OM-89 versus placebo in uncomplicated recurrent UTI in a large cohort of female…”
Get full text

PSA, PSA density, PSA density of transition zone, free/total PSA ratio, and PSA velocity for early detection of prostate cancer in men with serum PSA 2.5 to 4.0 ng/mL by Djavan, Bob, Zlotta, Alexandre, Kratzik, Christian, Remzi, Mesut, Seitz, Christian, Schulman, Claude C, Marberger, Michael

“…Objectives. To enhance the specificity of prostate cancer (PCa) detection and reduce unnecessary biopsies in men with prostate-specific antigen (PSA) levels of…”
Get full text